What are the normal serum beta‑hydroxybutyrate (BHB) levels, and at what concentrations does BHB indicate nutritional ketosis versus pathological ketosis such as diabetic ketoacidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Beta-Hydroxybutyrate Levels: Normal Values and Diagnostic Thresholds

Normal serum beta-hydroxybutyrate (BHB) levels are below detection limits (<0.3 mmol/L), nutritional ketosis ranges from 0.3–4 mmol/L with normal pH and glucose, while pathological ketosis (diabetic ketoacidosis) is characterized by BHB levels >7–8 mmol/L accompanied by pH <7.30, glucose >250 mg/dL, and bicarbonate <15 mEq/L. 1, 2

Normal and Physiological Ketosis Ranges

  • Healthy fasting individuals maintain BHB levels below 0.3 mmol/L under normal conditions, with up to 30% of first-morning urine samples showing trace ketones even in asymptomatic adults. 2, 3

  • Nutritional or physiological ketosis—induced by carbohydrate restriction (<50 g/day), prolonged fasting, or ketogenic diets—produces BHB concentrations of 0.3–4 mmol/L while maintaining normal blood glucose, normal pH, and serum bicarbonate ≥18 mEq/L. 1, 3

  • During extended fasting, glycogen depletion triggers fatty acid oxidation, generating ketones that serve as alternative fuel for skeletal muscle, cardiac muscle, and other tissues while sparing glucose for the brain. 3

Pathological Ketosis Thresholds

  • Diabetic ketoacidosis (DKA) requires BHB levels ≥3.8 mmol/L in adults (≥3.0 mmol/L in children) combined with glucose >250 mg/dL, arterial pH <7.30, serum bicarbonate <15 mEq/L, and anion gap >10 mEq/L. 4, 5

  • Pathological ketosis in decompensated diabetes presents with BHB >7–8 mmol/L, severely low pH, absent or deficient insulin, and hyperglycemia—representing a medical emergency. 1, 3

  • Research demonstrates that BHB ≥1 mmol/L has 85.1% sensitivity and 95.3% specificity for diagnosing diabetic ketosis/ketoacidosis, while levels <0.66 mmol/L effectively rule out DKA (99.9% negative predictive value). 6

Clinical Action Thresholds

The American College of Clinical Endocrinologists recommends the following blood BHB action thresholds for patients at risk of ketosis: 2, 3

  • <0.5 mmol/L: No intervention required
  • 0.5–1.5 mmol/L: Initiate sick-day rules (oral hydration, supplemental short-acting insulin with carbohydrate intake, frequent glucose/ketone monitoring)
  • ≥1.5 mmol/L: Seek immediate medical attention; intravenous insulin therapy typically required

Critical Diagnostic Considerations

  • Blood BHB measurement is strongly preferred over urine dipstick testing for all clinical decision-making, because standard urine dipsticks detect only acetoacetate and miss BHB—the predominant ketone body in DKA—leading to significant underestimation of total ketone burden. 2, 3, 4

  • The nitroprusside method (standard urine dipstick) has sensitivity as low as 35–52% for mild-to-moderate ketosis and should never be used to monitor DKA treatment response, as acetoacetate may paradoxically rise while BHB falls during successful therapy. 2, 4

  • When evaluating suspected DKA, immediately check blood glucose to distinguish between pathological ketoacidosis and benign starvation ketosis; glucose >250 mg/dL indicates a medical emergency requiring full DKA workup. 2, 3

Special Populations and Pitfalls

  • SGLT2 inhibitors increase DKA risk and can cause euglycemic DKA where glucose may be <250 mg/dL despite severe ketoacidosis (BHB ≥3.8 mmol/L), complicating timely diagnosis. 2, 4, 7

  • Pregnant women (with or without diabetes) show positive urine ketones in up to 30% of first-morning samples, reflecting normal metabolic adaptation rather than pathology. 2, 3

  • Alcoholic ketoacidosis produces positive ketones but typically without hyperglycemia, distinguishing it from DKA. 2

  • Independent of treatment, DKA risk increases by 18% with each 0.1 mmol/L increase in baseline BHB and by 8% with each 0.1 mmol/L increase from baseline during therapy. 7

High-Risk Patients Requiring Immediate Evaluation

Patients with the following characteristics warrant immediate BHB measurement and DKA evaluation when ketones are detected: 2, 3

  • Known type 1 diabetes or history of prior DKA
  • Currently on SGLT2 inhibitor therapy
  • Unexplained hyperglycemia (>300 mg/dL persistently)
  • Acute illness, infection, or physiological stress
  • Symptoms of ketoacidosis (nausea, vomiting, abdominal pain, Kussmaul respirations, altered mental status)

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diabetic Ketoacidosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ketone Production During Fasting: Critical Distinction Between Healthy Individuals and Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diabetic Ketoacidosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[The diagnostic value of serum beta-hydroxybutyrate in diabetic ketosis or diabetic ketoacidosis].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.